Skip to content

OAKTREE ACQUISITION CORP. III LIFE SCIENCES

OACC OACCU OACCW

CIK 0002029769

← back to feed
Revenue (TTM)
—
Q1 Mar 2026
Net Income (TTM)
$6.89M
+447.3% YoY Q1 Mar 2026
EPS Diluted (TTM)
—
Q1 Mar 2026
Gross Margin
—
Q1 Mar 2026
Operating Margin
—
Q1 Mar 2026
Net Margin
—
Q1 Mar 2026
Free Cash Flow (TTM)
—
Q1 Mar 2026
Cash
$1.28M
Q1 Mar 2026
Total Debt
—
Q1 Mar 2026
Shares Outstanding
—
Q1 Mar 2026

Revenue & Net Income

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings